Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Becker's Hospital Review14d
New weight loss pill to be approved by early 2026: Eli Lilly
Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13, according to a Wall Street Journal report.
Hosted on MSN1mon
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Analysts say Eli Lilly may have a future blockbuster drug on its hands: An experimental pill designed to lower ... so lifestyle changes such as diet or exercise have no effect, Ruth Gimeno ...
Eli Lilly CEO tells Bloomberg TV company sees weight loss pill approval in 2026
Eli Lilly (LLY) expects that its experimental weight loss pill will get approved as soon as early next year, CEO David Ricks said in an ...
Oral Ozempic and a ‘miracle’ pill imitating the keto diet – a new era of weight loss is here
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they really work? Zoë Beaty looks at how the health landscape is rapidly changing to ...
New York Post22d
Ozempic 3.0? This drug causes the greatest weight loss — by far
Eli Lilly’s retatrutide is called “triple G ... Liraglutide, a daily GLP-1 drug, brought weight loss of up to 5.8% after 26 weeks. A pill form of semaglutide brought similar weight loss ...
Kiplinger7mon
The Future of Weight-Loss Drugs for Investors
Traders are comparing U.S. weight-loss drug innovator Eli Lilly to artificial ... Baron ranks Structure second behind Lilly in the race to get a weight-loss pill to market. Structure is also ...